soul trial oral semaglutide cardiovascular outcomes results 2025 nejm In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc NEJM Editorial Fellow Harleen Marwah,

Lactobacillus strains have been widely demonstrated to metabolize tryptophan into its derivatives, such as indole-3-aldehyde (IAld), indole-3-lactic acid (ILA), and indole-3-acetic acid (IAA) 64,68,69

Long-term investigation in older adults confirms these benefits extend over time

Collectively, these studies provide evidence that the L-carnitine system is differentially impacted by APOE genotypes with age and following L-carnitine challenge which could later contribute to AD pathogenesis through bioenergetics deficits, FA toxicity, and cerebrovascular dysfunction in E4s, especially in females

Es necesario refrigerarlo